HQY - HealthEquity Inc Stock Price, Fair Value and News

78.06USD-2.32 (-2.89%)Market Closed

Market Summary

USD78.06-2.32

Market Closed

-2.89%

HQY Alerts

Big jump in Earnings (Y/Y)

HQY Stock Price

View Fullscreen

HQY RSI Chart

HQY Valuation

Market Cap

6.7B

Price/Earnings (Trailing)

120.72

Price/Sales (Trailing)

6.73

EV/EBITDA

29.09

Price/Free Cashflow

27.89

HQY Price/Sales (Trailing)

HQY Profitability

EBT Margin

7.51%

Return on Equity

2.74%

Return on Assets

1.76%

Free Cashflow Yield

3.59%

HQY Fundamentals

HQY Revenue

Revenue (TTM)

999.6M

Rev. Growth (Yr)

12.21%

Rev. Growth (Qtr)

5.28%

HQY Earnings

Earnings (TTM)

55.7M

Earnings Growth (Yr)

12.7K%

Earnings Growth (Qtr)

79.68%

Breaking Down HQY Revenue

Last 7 days

-2.1%

Last 30 days

-1.4%

Last 90 days

0.0%

Trailing 12 Months

40.5%

How does HQY drawdown profile look like?

HQY Financial Health

Current Ratio

4.76

Debt/Equity

0.43

Debt/Cashflow

0.28

HQY Investor Care

Shares Dilution (1Y)

1.65%

Diluted EPS (TTM)

0.64

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	999.6M	0	0	0
2023	861.7M	900.5M	937.9M	971.0M
2022	756.6M	778.0M	795.1M	831.2M
2021	733.6M	727.8M	740.8M	741.4M
2020	532.0M	635.0M	724.4M	746.6M
2019	287.2M	304.4M	319.9M	406.6M
2018	229.5M	244.0M	258.2M	271.9M
2017	178.4M	189.8M	202.5M	215.9M
2016	126.8M	140.9M	154.6M	167.4M
2015	87.9M	97.5M	107.1M	115.8M
2014	62.0M	67.6M	73.5M	80.1M
2013	46.1M	50.1M	54.1M	58.0M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of HealthEquity Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 03, 2024	rosner elimelech	sold (taxes)	-258,630	80.5952	-3,209	evp, chief technology officer
Apr 03, 2024	ladd delano	sold (taxes)	-135,723	80.5956	-1,684	evp, gc & corporate secretary
Apr 03, 2024	neeleman stephen	sold (taxes)	-159,902	80.5959	-1,984	founder and vice chairman
Apr 02, 2024	ladd delano	sold (taxes)	-109,042	81.863	-1,332	evp, gc & corporate secretary
Apr 02, 2024	neeleman stephen	sold (taxes)	-143,342	81.863	-1,751	founder and vice chairman
Apr 01, 2024	ladd delano	sold (taxes)	-279,009	80.6151	-3,461	evp, gc & corporate secretary
Apr 01, 2024	kessler jon	sold (taxes)	-4,296,380	80.6151	-53,295	president and ceo
Apr 01, 2024	neeleman stephen	sold (taxes)	-431,130	80.6151	-5,348	founder and vice chairman
Mar 27, 2024	kessler jon	acquired	-	-	103,806	president and ceo
Mar 27, 2024	ladd delano	acquired	-	-	24,255	evp, gc & corporate secretary

Which funds bought or sold HQY recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 07, 2024	Inspire Investing, LLC	added	169	890,050	1,273,200	0.13%
May 07, 2024	TimesSquare Capital Management, LLC	reduced	-14.75	1,001,000	21,161,000	0.31%
May 07, 2024	OPPENHEIMER ASSET MANAGEMENT INC.	reduced	-14.46	204,473	4,052,190	0.06%
May 07, 2024	CIM INVESTMENT MANAGEMENT INC	unchanged	-	78,398	417,456	0.12%
May 07, 2024	SEI INVESTMENTS CO	added	2.33	9,597,540	46,533,100	0.07%
May 07, 2024	Washington Trust Advisors, Inc.	unchanged	-	2,193	11,674	-%
May 07, 2024	Swiss National Bank	added	0.36	2,635,150	13,820,000	0.01%
May 07, 2024	Headlands Technologies LLC	new	-	130,200	130,200	0.03%
May 07, 2024	SUSQUEHANNA INTERNATIONAL GROUP, LLP	reduced	-68.67	-1,416,910	889,931	-%
May 07, 2024	M&T Bank Corp	added	4.9	911,110	4,038,810	0.01%

Are Funds Buying or Selling HQY?

Are funds buying HQY calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own HQY

No. of Funds

HQY Alerts

Big jump in Earnings (Y/Y)

Unveiling HealthEquity Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	10.05%	8,619,499	SC 13G/A
Feb 09, 2024	wasatch advisors lp	-	0	SC 13G/A
Feb 09, 2024	fmr llc	-	0	SC 13G/A
Jan 23, 2024	blackrock inc.	12.3%	10,591,921	SC 13G/A
Dec 08, 2023	vanguard group inc	10.05%	8,603,307	SC 13G/A
Feb 09, 2023	fmr llc	-	0	SC 13G
Feb 09, 2023	vanguard group inc	9.83%	8,319,745	SC 13G/A
Feb 08, 2023	wasatch advisors inc	-	0	SC 13G/A
Feb 01, 2023	blackrock inc.	12.3%	10,422,979	SC 13G/A
Feb 11, 2022	jackson square partners, llc	0%	0	SC 13G/A

Recent SEC filings of HealthEquity Inc

View All Filings

Date Filed	Form Type	Document
Apr 25, 2024	8-K	Current Report
Apr 15, 2024	8-K	Current Report
Apr 05, 2024	4	Insider Trading
Apr 05, 2024	4	Insider Trading
Apr 05, 2024	4	Insider Trading
Apr 03, 2024	4	Insider Trading
Apr 03, 2024	4	Insider Trading
Apr 03, 2024	4	Insider Trading
Mar 29, 2024	3	Insider Trading
Mar 29, 2024	4	Insider Trading

Peers (Alternatives to HealthEquity Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	463.9B	371.6B	10.35%	2.61%	20.73	1.25	14.64%	11.24%
CI	98.7B	206.0B	-2.97%	32.18%	25.6	0.48	12.55%	-43.95%
HCA	81.0B	66.7B	-5.69%	12.88%	14.81	1.21	9.59%	-4.59%
CVS	68.9B	360.9B	-26.25%	-21.54%	9.41	0.19	9.07%	78.49%
CNC	40.5B	155.5B	3.95%	12.19%	14.8	0.26	6.34%	84.42%
DVA	11.9B	12.3B	1.61%	34.91%	14.61	0.97	5.77%	58.74%
UHS	11.7B	14.3B	-1.27%	18.38%	16.36	0.82	6.59%	6.24%
MID-CAP
CHE	8.6B	2.3B	-8.25%	4.64%	30.5	3.77	5.96%	18.29%
ACHC	6.1B	3.0B	-12.48%	-3.87%	-542.08	2.05	10.92%	-104.06%
AMN	2.3B	3.8B	2.67%	-35.23%	10.84	0.6	-27.73%	-52.50%
AMEH	2.1B	1.4B	-9.72%	19.70%	34.78	1.52	21.19%	34.42%
SMALL-CAP
ADUS	1.8B	1.1B	5.80%	29.14%	26.69	1.61	11.45%	30.74%
BKD	1.3B	3.0B	1.30%	77.47%	-7.02	0.44	6.74%	20.73%
BEAT	54.0M	-	-4.65%	-8.89%	-3.69	-	-	-12.94%
AMS	19.4M	21.3M	3.37%	9.25%	36.46	0.91	8.00%	-62.25%

HealthEquity Inc News

Latest updates

HealthEquity Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	5.3%	262	249	244	244	234	216	206	206	203	180	189	184	188	179	176	190	201	157	87.00	87.00	76.00
Gross Profit	2.6%	163	159	152	148	135	127	118	112	106	104	112	103	101	105	102	108	114	96.00	58.00	58.00	44.00
Operating Expenses	-3.0%	124	128	127	125	122	122	121	119	133	104	113	99.00	103	93.00	93.00	93.00	99.00	86.00	34.00	30.00	28.00
S&GA Expenses	4.6%	21.00	20.00	19.00	20.00	19.00	17.00	16.00	17.00	16.00	13.00	15.00	14.00	13.00	13.00	12.00	11.00	14.00	13.00	8.00	9.00	8.00
R&D Expenses	-0.7%	55.00	56.00	55.00	53.00	53.00	49.00	47.00	45.00	46.00	38.00	38.00	35.00	32.00	31.00	31.00	31.00	32.00	24.00	12.00	11.00	10.00
EBITDA Margin	8.1%	0.25*	0.23*	0.21*	0.18*	0.16*	0.09*	0.09*	0.10*	0.10*	0.14*	0.15*	0.17*	-	-	-	-	-	-	-	-	-
Interest Expenses	0.7%	14.00	14.00	13.00	15.00	14.00	12.00	11.00	10.00	11.00	12.00	7.00	7.00	7.00	7.00	9.00	12.00	14.00	10.00	0.00	0.00	-0.08
Income Taxes	-47.7%	3.00	6.00	4.00	6.00	0.00	-4.54	-3.22	-4.41	-10.95	-4.09	-3.97	-3.45	-6.71	2.00	-0.54	0.00	-0.42	-9.92	4.00	9.00	3.00
Earnings Before Taxes	40.9%	30.00	21.00	14.00	10.00	0.00	-6.18	-13.87	-18.05	-43.76	-9.12	-7.78	-6.07	-1.34	4.00	-0.69	2.00	-0.61	-31.25	24.00	51.00	16.00
EBT Margin	60.8%	0.08*	0.05*	0.02*	-0.01*	-0.04*	-0.10*	-0.11*	-0.10*	-0.09*	-0.03*	-0.01*	-0.01*	-	-	-	-	-	-	-	-	-
Net Income	79.7%	26.00	15.00	11.00	4.00	-0.21	-1.64	-10.65	-13.64	-32.82	-5.04	-3.82	-2.61	5.00	2.00	-0.15	2.00	-0.19	-21.33	19.00	42.00	13.00
Net Income Margin	85.7%	0.06*	0.03*	0.01*	-0.01*	-0.03*	-0.07*	-0.08*	-0.07*	-0.06*	-0.01*	0.00*	0.01*	-	-	-	-	-	-	-	-	-
Free Cashflow	35.3%	77.00	57.00	77.00	31.00	55.00	47.00	39.00	6.00	49.00	21.00	33.00	28.00	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	2.3%	3,164	3,094	3,066	3,035	3,089	3,065	3,074	3,065	3,107	3,100	3,149	3,162	2,710	2,657	2,664	2,562	2,565	2,560	1,098	597	510
Current Assets	17.5%	557	474	423	358	383	332	309	279	351	764	861	865	460	396	383	284	297	270	854	365	395
Cash Equivalents	20.9%	404	334	290	226	254	210	177	161	225	649	754	737	329	299	269	171	192	175	815	329	361
Net PPE	-21.5%	6.00	8.00	9.00	11.00	13.00	16.00	18.00	21.00	23.00	25.00	27.00	27.00	29.00	32.00	35.00	36.00	33.00	35.00	10.00	8.00	8.00
Goodwill	0%	1,648	1,648	1,648	1,648	1,648	1,646	1,646	36.00	1,646	282	1,364	1,364	1,327	1,327	1,334	1,333	1,333	1,323	5.00	5.00	5.00
Liabilities	2.1%	1,129	1,106	1,117	1,116	1,193	1,182	1,209	1,210	1,255	1,228	1,286	1,314	1,332	1,302	1,324	1,522	1,535	1,542	81.00	67.00	33.00
Current Liabilities	21.7%	117	96.00	103	90.00	131	110	126	118	153	107	185	192	205	151	154	135	152	142	37.00	23.00	29.00
Long Term Debt	0.1%	875	874	874	873	908	911	915	919	922	924	895	910	924	939	953	1,167	1,182	1,196	-	-	-
LT Debt, Current	-	-	-	-	-	18.00	15.00	13.00	11.00	9.00	7.00	78.00	63.00	63.00	63.00	55.00	47.00	39.00	31.00	-	-	-
LT Debt, Non Current	0.1%	875	874	874	873	908	911	915	919	922	924	895	910	924	939	953	1,167	1,182	1,196	-	-	-
Shareholder's Equity	2.4%	2,035	1,988	1,950	1,919	1,896	1,883	1,865	1,855	1,853	1,872	1,863	1,848	1,379	1,355	1,340	1,041	1,030	1,018	1,017	529	477
Retained Earnings	14.7%	206	179	165	154	150	150	152	162	176	209	214	218	220	215	213	213	212	212	233	214	172
Additional Paid-In Capital	1.1%	1,829	1,809	1,785	1,765	1,746	1,733	1,713	1,693	1,677	1,663	1,649	1,631	1,158	1,140	1,127	827	819	806	784	316	305
Accumulated Depreciation	-10.6%	41.00	46.00	45.00	43.00	42.00	41.00	40.00	38.00	36.00	39.00	36.00	33.00	31.00	27.00	23.00	19.00	16.00	14.00	11.00	10.00	9.00
Shares Outstanding	0.4%	86.00	86.00	86.00	85.00	85.00	85.00	84.00	84.00	83.00	84.00	83.00	82.00	-	-	-	-	-	-	-	-	-
Float	-	-	-	5,100	-	-	-	4,300	-	-	-	6,100	-	-	-	3,900	-	-	-	5,700	-	-

Cashflow (Last 12 Months)

(In Millions)

Cashflow (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	35.0%	77.00	57.00	77.00	32.00	55.00	48.00	40.00	7.00	51.00	22.00	37.00	31.00	61.00	52.00	54.00	15.00	31.00	17.00	31.00	25.00	33.00
Share Based Compensation	-20.5%	17.00	22.00	20.00	18.00	12.00	18.00	18.00	14.00	11.00	13.00	16.00	13.00	13.00	11.00	11.00	7.00	9.00	18.00	8.00	6.00	6.00
Cashflow From Investing	26.9%	-11.27	-15.42	-10.25	-9.13	-10.28	-13.53	-21.12	-74.20	-471	-79.68	-20.47	-67.80	-20.23	-21.03	-30.40	-25.29	-25.10	-1,646	-6.86	-61.73	38.00
Cashflow From Financing	102.9%	4.00	2.00	-2.15	-51.03	-1.15	-1.09	-3.39	3.00	-2.97	-47.22	0.00	445	-11.22	-0.57	75.00	-10.36	11.00	989	461	4.00	2.00

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

HQY Income Statement

2024-01-31

Consolidated statements of operations and comprehensive income (loss) - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Revenue
Total revenue	$ 999,587	$ 861,748	$ 756,556
Cost of revenue
Total cost of revenue	376,950	369,813	331,791
Gross profit	622,637	491,935	424,765
Operating expenses
Sales and marketing	79,273	68,849	58,605
Technology and development	218,811	193,375	157,364
General and administrative	103,656	97,472	85,438
Amortization of acquired intangible assets	92,763	94,586	82,791
Merger integration	10,435	28,596	64,805
Total operating expenses	504,938	482,878	449,003
Income (loss) from operations	117,699	9,057	(24,238)
Other expense
Interest expense	(55,455)	(48,424)	(36,572)
Other income (expense), net	12,796	1,271	(5,931)
Total other expense	(42,659)	(47,153)	(42,503)
Income (loss) before income taxes	75,040	(38,096)	(66,741)
Income tax provision (benefit)	19,328	(11,953)	(22,452)
Net income (loss)	55,712	(26,143)	(44,289)
Comprehensive income (loss)	$ 55,712	$ (26,143)	$ (44,289)
Net income (loss) per share:
Basic (in usd per share)	$ 0.65	$ (0.31)	$ (0.53)
Diluted (in usd per share)	$ 0.64	$ (0.31)	$ (0.53)
Weighted-average number of shares used in computing net income (loss) per share:
Basic (in shares)	85,564	84,442	83,133
Diluted (in shares)	86,957	84,442	83,133
Service revenue
Revenue
Total revenue	$ 455,690	$ 452,026	$ 443,608
Cost of revenue
Total cost of revenue	317,357	318,516	291,618
Custodial revenue
Revenue
Total revenue	386,594	261,282	186,119
Cost of revenue
Total cost of revenue	32,502	26,101	19,492
Interchange revenue
Revenue
Total revenue	157,303	148,440	126,829
Cost of revenue
Total cost of revenue	$ 27,091	$ 25,196	$ 20,681

HQY Balance Sheet

2024-01-31

Consolidated balance sheets - USD ($) $ in Thousands	Jan. 31, 2024	Jan. 31, 2023
Current assets
Cash and cash equivalents	$ 403,979	$ 254,266
Accounts receivable, net of allowance for doubtful accounts of $3,947 and $4,989 as of January 31, 2024 and 2023, respectively	104,893	96,835
Other current assets	48,564	31,792
Total current assets	557,436	382,893
Property and equipment, net	6,013	12,862
Operating lease right-of-use assets	48,380	56,461
Intangible assets, net	835,948	936,359
Goodwill	1,648,145	1,648,145
Other assets	67,868	52,180
Total assets	3,163,790	3,088,900
Current liabilities
Accounts payable	12,041	13,899
Accrued compensation	49,608	45,835
Accrued liabilities	46,038	43,668
Current portion of long-term debt	0	17,500
Operating lease liabilities	9,404	10,159
Total current liabilities	117,091	131,061
Long-term liabilities
Long-term debt, net of issuance costs	874,972	907,838
Operating lease liabilities, non-current	48,766	58,988
Other long-term liabilities	19,270	12,708
Deferred tax liability	68,670	82,665
Total long-term liabilities	1,011,678	1,062,199
Total liabilities	1,128,769	1,193,260
Commitments and contingencies (see Note 7)
Stockholders’ equity
Preferred stock, $0.0001 par value, 100,000 shares authorized, no shares issued and outstanding as of January 31, 2024 and 2023	0	0
Common stock, $0.0001 par value, 900,000 shares authorized, 86,127 and 84,758 shares issued and outstanding as of January 31, 2024 and 2023, respectively	9	8
Additional paid-in capital	1,829,384	1,745,716
Accumulated earnings	205,628	149,916
Total stockholders’ equity	2,035,021	1,895,640
Total liabilities and stockholders’ equity	$ 3,163,790	$ 3,088,900

About HealthEquity Inc

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is headquartered in Draper, Utah.

CEO	Mr. Jon Kessler
WEBSITE	healthequity.com
INDUSTRY	Healthcare Plans
EMPLOYEES	3170

HealthEquity Inc Frequently Asked Questions

What is the ticker symbol for HealthEquity Inc? What does HQY stand for in stocks?

HQY is the stock ticker symbol of HealthEquity Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of HealthEquity Inc (HQY)?

As of Wed May 08 2024, market cap of HealthEquity Inc is 6.73 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of HQY stock?

You can check HQY's fair value in chart for subscribers.

What is the fair value of HQY stock?

You can check HQY's fair value in chart for subscribers. The fair value of HealthEquity Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of HealthEquity Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for HQY so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is HealthEquity Inc a good stock to buy?

The fair value guage provides a quick view whether HQY is over valued or under valued. Whether HealthEquity Inc is cheap or expensive depends on the assumptions which impact HealthEquity Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for HQY.

What is HealthEquity Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed May 08 2024, HQY's PE ratio (Price to Earnings) is 120.72 and Price to Sales (PS) ratio is 6.73. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. HQY PE ratio will change depending on the future growth rate expectations of investors.